National Centre for Pharmacoeconomics

National Centre for
Pharmacoeconomics

NCPE Ireland

Pegvaliase (Palynziq®) HTA ID: 21057

Pegvaliase is indicated for the treatment of patients with phenylketonuria aged 16 years and older who have inadequate blood phenylalanine control (blood phenylalanine levels greater than 600 micromol/l) despite prior management with available treatment options.

NCPE Assessment Process Resubmission
For further details of previous submission see:  Pegvaliase (Palynziq®) HTA ID: 20001
Full re-submission received from Applicant 18/11/2021
Current status Full submission received from applicant